Literature DB >> 14987889

Dual HIV-1 infection associated with rapid disease progression.

Geoffrey S Gottlieb1, David C Nickle, Mark A Jensen, Kim G Wong, Jandre Grobler, Fusheng Li, Shan-Lu Liu, Cecilia Rademeyer, Gerald H Learn, Salim S Abdool Karim, Carolyn Williamson, Lawrence Corey, Joseph B Margolick, James I Mullins.   

Abstract

Infection with two strains of HIV-1 has implications for understanding HIV transmission and vaccine development; however, frequency and pathogenic consequences of dual infection are unknown. We assessed 64 patients for dual infection with heteroduplex mobility assay, viral sequencing, and phylogenetic methods. HIV disease outcomes were available in 34 patients. Five of these with AIDS endpoints had dual infection with HIV-1: four were cases of coinfection and one was superinfection. In all five, time from seroconversion to clinical AIDS or to CD4+ T-cell count less than 200 cells per microL was very rapid (<3.4 and <3.1 years, respectively). Our findings should prompt larger studies to assess the effect of dual infection at the population level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14987889     DOI: 10.1016/S0140-6736(04)15596-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  81 in total

Review 1.  New ways of preventing HIV infection: thinking simply, simply thinking.

Authors:  R V Short
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

2.  Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus.

Authors:  Rebecca L R Powell; Thompson Kinge; Phillipe N Nyambi
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

3.  Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier.

Authors:  Zenda Woodman; Koleka Mlisana; Florette Treurnicht; Melissa-Rose Abrahams; Ruwayida Thebus; Salim Abdool Karim; Carolyn Williamson
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-09       Impact factor: 2.205

4.  HIV diversity, molecular epidemiology, and the role of recombination.

Authors:  Gustavo H Kijak; Francine E McCutchan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

Review 5.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

6.  Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.

Authors:  David V Jobes; Melissa Daoust; Vivian T Nguyen; Allan Padua; Faruk Sinangil; Marcos Pérez-Losada; Keith A Crandall; Theodore Oliphant; David Posada; Andrew Rambaut; Jonathan Fuchs; Phillip W Berman
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

7.  Evaluation of change in CD4+ cell counts in AIDS clinical trials.

Authors:  H Liang
Journal:  Stat Methods Med Res       Date:  2007-08-14       Impact factor: 3.021

8.  Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Authors:  Antoine Chaillon; Gabriel A Wagner; N Lance Hepler; Susan J Little; Sergei L Kosakovsky Pond; Gemma Caballero; Mary E Pacold; Pham Phung; Terri Wrin; Douglas D Richman; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  Short Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid Progressor.

Authors:  Kerry Gordon; Shatha Omar; Andile Nofemela; Gama Bandawe; Carolyn Williamson; Zenda Woodman
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-20       Impact factor: 2.205

10.  Molecular epidemiology of HIV type 1 subtypes in Rwanda.

Authors:  Kimdar S Kemal; Kathryn Anastos; Barbara Weiser; Christina M Ramirez; Qiuhu Shi; Harold Burger
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-01       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.